Sign In
Sign Up
Two Blokes
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates
click to rate
Posted by
Two Blokes
Jun 28
- Filed in
Stock
- 4 views
IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.04 per share a year ago.